Safety and metabolic tolerance of a concentrated long-chain triglyceride lipid emulsion in critically ill septic and trauma patients

Journal of Parenteral and Enteral Nutrition

Volumn 27, Issue 3, 2003, Pages 208-215

  García de Lorenzo, Abelardo ^a,k   López Martínez, Jorge ^b   Planas, Mercé ^c   Chacón, Pilar ^c   Montejo, Juan C ^d   Bonet, Alfonso ^e   Ortiz Leyba, Carlos ^f   Sánchez Segura, Juan M ^g   Ordóñez, Javier ^h   Acosta, Jose ⁱ   Grau, Teodoro ^j   Jiménez, Francisco J ^f  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL JOSEP TRUETA   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^j HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^k C/ Nuria 28 2oA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; INTRALIPID; LIPID EMULSION; LIPOPROTEIN; LIPOPROTEIN X; LONG CHAIN TRIACYLGLYCEROL; NITROGEN; PHOSPHOLIPID; PLASMA PROTEIN; PREALBUMIN; RETINOL BINDING PROTEIN; SERUM ALBUMIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CALORIE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DEATH; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; INJURY; KIDNEY FUNCTION; LIPID METABOLISM; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SEPSIS; THROMBOCYTE COUNT; TOTAL PARENTERAL NUTRITION; UREA BLOOD LEVEL;

EID: 0037696214     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607103027003208     Document Type: Article

References (29)

1. Nijveldt RJ, Tan AM, Prins HA, et al: Use of a mixture of medium-chain triglycerides and long-chain triglycerides versus long-chain triglycerides in critically ill surgical patients: A randomized prospective double-blind study. Clin Nutr 17:23-29, 1998
2. Druml W, Fischer M, Ratheiser K: Use of intravenous lipids in critically ill patients with sepsis without and with hepatic failure. JPEN 22:217-223, 1998
3. Dupont IE, Carpentier YA: Clinical use of lipid emulsions. Curr Opin Clin Nutr Metab Care 2:139-145, 1999
4. Olivecrona G, Olivecrona T: Clearance of artificial triacylglycerol particles. Curr Opin Clin Nutr Metab Care 1:143-151, 1998
5. Haumont D, Deckelbaum J, Richelle M, et al: Plasma lipid and plasma lipoprotein concentration in low birth weight infants given parenteral nutrition with twenty or ten percent lipid emulsion. J Pediatr 115:787-793, 1989
6. Westling K, Wennberg A, Jonsson M: A lower increase in serum LDL cholesterol and phospholipids after infusion of a 30% lipid emulsion as compared to a 20% lipid emulsion in dogs. Clin Nutr 8(suppl):100-109, 1989
7. Dahlan W, Richelle M, Kulapongse S, et al: Modification of erythrocyte membrane lipid composition induced by a single intravenous infusion of phospholipid-triacylglycerol emulsions in man. Clin Nutr 11:255-262, 1992
8. Ferezou J, Lai N-T, Leray C, et al: Lipid composition and structure of commercial parenteral emulsions. Biochim Biophys Acta 1213:149-158, 1994
9. Nordenstrom J, Thorne A: Comparative studies on a new concentrated fat emulsion: Intralipid 30% vs. 20%. Clin Nutr 12:160-167, 1993
10. Rotenberg M, Rubin M, Bor A, et al: Physico-chemical characterization of Intralipid emulsions. Biochim Biophys Acta 1086:265-272, 1991.
11. Carpentier YA, Nordenstrom J, Askanazi J: Interaction between exogenous fat and plasma lipoproteins. Infusionstherapie 14(suppl):29-32, 1987
12. Planas M, Porta I, Sagrista ML, et al: Fatty acid composition of platelet membrane lipids after administration of two different fat emulsion in critically ill patients. Intensive Care Med 25:395-398, 1999
13. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 43:1345-1353, 1955
14. Adolph M: Lipid emulsions in total parenteral nutrition - state of the art and future perspectives. Clin Nutr 20(suppl):11-14, 2001
15. Lindholm M, Rossner S: Rate of elimination of the intralipid fat emulsion from the circulation in ICU patients. Crit Care Med 10:740-746, 1982
16. Planas M, García A: Peroxidación lipídica en enfermos críticos. Nutr Hosp 12:233-236, 1997
17. Feingold KR, Staprans I, Memon RA, et al: Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: Low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33:1765-1776, 1992
18. Khovidhunkit W, Memon RA, Feingold KR, et al: Infection and inflammation induced proatherogenic changes of lipoproteins. J Infect Dis 181:S462-S472, 2000
19. Carpentier YA, Scruel O: Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 5:153-158, 2002
20. Kalfarentzos F, Kokkinis K, Leukaditi K, et al: Comparison between two fat emulsions: Intralipid 30% vs Intralipid 10% in critically ill patients. Clin Nutr 17:31-34, 1998
21. Weinberg RB, Singh KK: Short-term parenteral nutrition with glucose and Intralipid: Effects on serum lipids and lipoproteins. Am J Clin Nutr 49:794-798, 1989
22. Rye KA, Doung MN: Influence of phospholipid depletion on the size, structure and remodelling of reconstituted high density lipoproteins. J Lipid Res 41:1640-1650, 2000
23. Carpentier YA: Are present fat emulsions appropriate?. IN Metabolic Support of the Critically Ill Patient, Wilmore DW, Carpentier YA (eds). Springer-Verlag, Berlin, Germany, 1993, pp 157-171
24. Garcia-de-Lorenzo A, Ortiz C, Planas M, et al: Parenteral administration of different amounts of branch-chain amino acids in septic patients: Clinical and metabolic aspects. Crit Care Med 25:418-424, 1997
25. Prielipp RC, Butterwoth JF, Roberts PR, et al: Magnesium antagonizes the actions of lysophosphatidylcoline (LCP) in myocardial cells: A possible mechanism for its antiarrhythmic effects. Anesth Analg 80:1083-1087, 1995
26. Lewis TV, Dart AM, Chin-Dusting JP: Non-specific inhibition by human lipoproteins of endothelium dependent relaxation in rat aorta may be attributed to lipoprotein phospholipids. Cardiovasc Res 34:590-596, 1997
27. Stojiljkovic MP, Zhang D, Lopes HF, et al: Hemodynamic effects of lipids in humans. Am J Physiol Regul Integr Comp Physiol 280R:1674-1679, 2001
28. Garcia-de-Lorenzo A and the Metabolic Working Group of SEMICYUC: Lipid emulsions with different phospholipid/ triglyceride ratio in critically ill septic and traumatic patient. Crit Care Med 26:2094-2095, 1998
29. Van de Welde M, Wouters PF, Rolf N, et al: Comparative hemodynamic effects of three different parenterally administered lipid emulsions in conscious dogs. Crit Care Med 26:132-137, 1998